November 21, 2018 — Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in medical imaging, at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.
Watson Imaging Patient Synopsis is a radiologist-trained artificial intelligence (AI) tool that extracts relevant patient information summarized into tailored, specific and concise single-view reports to better inform diagnostic decisions. Guerbet will demonstrate Patient Synopsis at RSNA 2018 alongside its Digital Services offerings.
Guerbet, an IBM Business Partner, and IBM are finalizing the terms by which Guerbet will become the first reseller of Patient Synopsis. This planned reseller relationship is in addition to IBM and Guerbet's ongoing efforts to co-develop and distribute new clinical decision support solutions. Earlier this year, Guerbet signed a joint development agreement with IBM Watson Health to develop an AI software solution supporting liver cancer diagnostics and care.
Guerbet's Contrast&Care is also part of Guerbet's Digital Services offerings. It enables radiology departments to collect, archive, examine and share contrast injection data directly with Guerbet's injectors, advancing data transfer and accuracy in dosing to help radiologists best serve patients. Likewise, at RSNA, Guerbet will display Imalogix, a cloud-based performance management and dose monitoring solution already available in the USA market.
For more information: www.guerbet-us.com
July 16, 2026 
